Edition:
India

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

3.86USD
15 Dec 2017
Change (% chg)

$-0.21 (-5.16%)
Prev Close
$4.07
Open
$4.00
Day's High
$4.00
Day's Low
$3.82
Volume
89,380
Avg. Vol
57,101
52-wk High
$5.77
52-wk Low
$1.98

Select another date:

Tue, Dec 12 2017

BRIEF-Peregrine Pharma reports Q2 shr loss $0.31

* PEREGRINE PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR SECOND QUARTER OF FISCAL YEAR 2018 AND RECENT DEVELOPMENTS

BRIEF-Peregrine Pharma, Ronin Trading And SW Investment Management Announce Settlement Agreement

* PEREGRINE PHARMACEUTICALS, RONIN TRADING AND SW INVESTMENT MANAGEMENT ANNOUNCE SETTLEMENT AGREEMENT

BRIEF-Ronin Trading and SW Investment Management announce additional nominations to board of Peregrine pharmaceuticals

* Ronin Trading and SW Investment Management announce additional nominations to board of peregrine pharmaceuticals

BRIEF-Peregrine Pharmaceuticals appoints Mark Bamforth to board of Avid Bioservices and co

* Peregrine Pharmaceuticals announces appointment of Mark R. Bamforth to board of directors of Peregrine and Avid Bioservices Source text for Eikon: Further company coverage:

BRIEF-Peregrine Pharmaceuticals reports Q1 loss per share $0.06

* Peregrine Pharmaceuticals reports financial results for first quarter of fiscal year 2018 and recent developments

BRIEF-Peregrine Pharma appoints Roger Lias as Avid Bioservices president

* Peregrine Pharmaceuticals announces appointment of Roger J. Lias, PH.D. as president of Avid Bioservices

BRIEF-Peregrine announces measures to reduce costs, facilitate profitability and strengthen its operations

* Peregrine announces measures to reduce costs, facilitate profitability and strengthen its operations

BRIEF-Peregrine ‍says "to evaluate strategic options for advancing research and development business​"

* Peregrine Pharmaceuticals Inc - ‍continues to evaluate strategic options for advancing research and development business​

BRIEF-Ronin Trading, SW Investment Management issue letter to Peregrine Pharma employees​

* ‍Ronin Trading and SW Investment Management say issued a letter to Peregrine Pharmaceuticals' employees​

Select another date: